Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals

Diabetes Technology and Therapeutics

Volumn 16, Issue 11, 2014, Pages 728-734

  Cameron, Fraser ^a   Niemeyer, Günter ^b   Wilson, Darrell M ^c   Bequette, B Wayne ^a   Benassi, Kari S ^c   Clinton, Paula ^c   Buckingham, Bruce A ^c  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b DISNEY RESEARCH   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN LISPRO; ANTIDIABETIC AGENT; CARBOHYDRATE DIET; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADULT; ALGORITHM; ARTICLE; ARTIFICIAL PANCREAS; CARBOHYDRATE DIET; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; COHORT ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MEAL; POSTPRANDIAL STATE; PREDICTION; YOUNG ADULT; ADMINISTRATION AND DOSAGE; BLOOD; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; EVALUATION STUDY; FEMALE; MALE; PREDICTIVE VALUE; REPRODUCIBILITY; STATISTICAL MODEL; TIME FACTOR;

ADULT; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIETARY CARBOHYDRATES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN; MALE; MEALS; MODELS, STATISTICAL; PANCREAS, ARTIFICIAL; POSTPRANDIAL PERIOD; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84911946092     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0093     Document Type: Article

References (41)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
2. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
3. Bequette BW: Challenges and recent progress in the development of a closed-loop artificial pancreas. Annu Rev Control 2012;36:255-266.
4. Bequette BW: A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther 2005;7:28-47.
5. Cobelli C, Renard E, Kovatchev B: Artificial pancreas: past, present, future. Diabetes 2011;60:2672-282.
6. Hovorka R: Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol 2011;7:385-395.
7. Buckingham BA, Cameron F, Calhoun P, et al.: Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther 2013;15:622-627.
8. Steil GM: Algorithms for a closed-loop artificial pancreas: the case for proportional-integral-derivative control. J Diabetes Sci Technol 2013;7:1621-1631.
9. Weinzimer S, Steil G, Swan K, et al.: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939.
10. Atlas E, Nimri R, Miller S, et al.: MD-Logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care 2010;33:1072-1076.
11. Phillip M, Battelino T, Atlas E, et al.: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833.
12. Nimri R, Muller I, Atlas E, et al.: Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis. Pediatr Diabetes 2014;15:91-99.
13. Miller S, Nimri R, Atlas E, et al.: Automatic learning algorithm for the MD-Logic artificial pancreas system. Diabetes Technol Ther 2011;13:983-990.
14. Mauseth R, Wang Y, Dassau E, et al.: Proposed clinical application for tuning fuzzy logic controller of artificial pancreas utilizing a personalization factor. J Diabetes Sci Technol 2010;4:913-922.
15. Bequette BW: Algorithms for a closed-loop artificial pancreas: the case for model predictive control. J Diabetes Sci Technol 2013;7:1632-1643.
16. Grosman B, Dassau E, Zisser HC, et al.: Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events. J Diabetes Sci Technol 2010;4:961-975.
17. Parker RS, Doyle FJ III, Peppas NA: A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans Biomed Eng 1999;46:148-157.
18. Patek SD, Magni L, Dassau E, et al.: Modular closed-loop control of diabetes. IEEE Trans Biomed Eng 2012;59:2986-2999.
19. Hovorka R, Kumareswaran K, Harris J, et al.: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011;342:d1855.
20. Wilinska M, Budiman E, Taub M, et al.: Overnight closedloop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies. J Diabetes Sci Technol 2009;3:1109-1120.
21. Kovatchev B, Cobelli C, Renard E, et al.: Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol 2010;4:1374-1381.
22. Clarke WL, Anderson S, Breton M, et al.: Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol 2009;3: 1031-1038.
23. Cameron F, Bequette B, Buckingham B, et al.: A closedloop artificial pancreas based on risk management. J Diabetes Sci Technol 2011; 5:368-379.
24. Russell S, El-Khatib F, Nathan D, et al.: Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care 2012;35:2148-2155.
25. Cobry E, McFann K, Messer L, et al.: Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Technol Ther 2010;12:173-177.
26. Dassau E, Zisser H, Palerm CC, et al.: Modular artificial bcell system: a prototype for clinical research. J Diabetes Sci Technol 2008;2:863-872.
27. Cameron F, Niemeyer G: Predicting blood glucose levels around meals for patients with type I diabetes. In: 2010 Dynamic Systems and Control Conference. pp 289-296. Cambridge, MA: ASME, 2010.
28. Cameron F, Niemeyer G, Bequette BW: Extended multiple model prediction with application to blood glucose regulation. J Process Control 2012;22:1422-1432.
29. Centers for Disease Control and Prevention. National Center for Health Statistics. National Health and Nutrition Examination Survey Data. Hyattsville, MD: 2004.
30. Clarke W, Kovatchev B: Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther 2009; 11(Suppl 1):S-45-S-54.
31. Clarke WL, Cox D, Gonder-Frederick LA, et al.: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.
32. Kovatchev BP, Gonder-Frederick LA, Cox DJ, et al.: Evaluating the accuracy of continuous glucose-monitoring sensors. Diabetes Care 2004;27:1922-1928.
33. Nathan D, Kuenen J, Borg R, et al.: Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478.
34. Rodbard H, Jellinger P, Davidson J, et al.: Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009;15:540-559.
35. American Diabetes Association: Clinical practice recommendations: executive summary: standards of medical care in diabetes. Diabetes Care 2010;33(Suppl 1):S4-S5.
36. Elleri D, Allen J, Kumareswaran K, et al.: Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes. Diabetes Care 2013;36:838-844.
37. Breton M, Farret A, Bruttomesso D, et al.: Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237.
38. Dassau E, Zisser H, Harvey RA, et al.: Clinical evaluation of a personalized artificial pancreas. Diabetes Care 2013; 36:801-809.
39. Burdick J, Chase H, Slover R, et al.: Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics 2004;113:e221- e224.
40. O'Connell MA, Donath S, Cameron FJ: Poor adherence to integral daily tasks limits the efficacy of CSII in youth. Pediatr Diabetes 2011;12:556-559.
41. Baysal N, Cameron F, Buckingham B, et al.: Detecting sensor and insulin infusion set anomalies in an artificial pancreas. In: American Control Conference. Washington, DC: IEEE Control Systems Society, 2013:2935-2939.